Raia Drogasil (RADL.Y) Stock Overview
Engages in the retail sale of medicines, perfumes, personal hygiene and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
RADL.Y Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Raia Drogasil S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$4.47 |
| 52 Week High | R$5.08 |
| 52 Week Low | R$2.21 |
| Beta | 0.14 |
| 1 Month Change | 21.47% |
| 3 Month Change | 37.96% |
| 1 Year Change | 19.52% |
| 3 Year Change | 5.67% |
| 5 Year Change | -7.84% |
| Change since IPO | 16.35% |
Recent News & Updates
Recent updates
Shareholder Returns
| RADL.Y | US Consumer Retailing | US Market | |
|---|---|---|---|
| 7D | 4.2% | 2.8% | 3.5% |
| 1Y | 19.5% | 7.1% | 12.0% |
Return vs Industry: RADL.Y exceeded the US Consumer Retailing industry which returned 8% over the past year.
Return vs Market: RADL.Y exceeded the US Market which returned 12.5% over the past year.
Price Volatility
| RADL.Y volatility | |
|---|---|
| RADL.Y Average Weekly Movement | 11.7% |
| Consumer Retailing Industry Average Movement | 5.0% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.2% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: RADL.Y's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: RADL.Y's weekly volatility has decreased from 17% to 12% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1905 | 69,860 | Renato Raduan | rdsaude.com.br |
Raia Drogasil S.A. engages in the retail sale of medicines, perfumes, personal hygiene and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.
Raia Drogasil S.A. Fundamentals Summary
| RADL.Y fundamental statistics | |
|---|---|
| Market cap | US$7.57b |
| Earnings (TTM) | US$250.34m |
| Revenue (TTM) | US$7.89b |
Is RADL.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RADL.Y income statement (TTM) | |
|---|---|
| Revenue | R$42.23b |
| Cost of Revenue | R$29.85b |
| Gross Profit | R$12.39b |
| Other Expenses | R$11.05b |
| Earnings | R$1.34b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.78 |
| Gross Margin | 29.33% |
| Net Profit Margin | 3.17% |
| Debt/Equity Ratio | 46.8% |
How did RADL.Y perform over the long term?
See historical performance and comparisonDividends
Does RADL.Y pay a reliable dividends?
See RADL.Y dividend history and benchmarks| Raia Drogasil dividend dates | |
|---|---|
| Ex Dividend Date | Apr 14 2025 |
| Dividend Pay Date | Dec 11 2025 |
| Days until Ex dividend | 229 days |
| Days until Dividend pay date | 12 days |
Does RADL.Y pay a reliable dividends?
See RADL.Y dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/28 13:01 |
| End of Day Share Price | 2025/11/26 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Raia Drogasil S.A. is covered by 24 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Andréa Aznar | BB Banco de Investimento S.A. |
| Robert Ford Aguilar | BofA Global Research |
| Frederico Mendes | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |